LakeShore Biopharma (LSB) Q2 2025 Earnings

31JulConfirmed
Q2 2024
Q3 2024
Q3 2024
Q2 2025
-0.94
-0.62
-0.3
0.02

Details

Expected EPS
N/A
Actual EPS
-0.73
Surprise EPS
-0.73
Surprise Percent
+∞%

Description

LakeShore Biopharma (LSB) has reported earnings of -0.73 per share for Q2 2025.

0 Comments

Share your thoughts